E-LIB Suche - Ergebnisse für: Qiu, Lugui

1

CRIP1 involves the pathogenesis of multiple myeloma via dua..:

Tang, Peixia ; Yu, Zhen ; Sun, Hao...
eBioMedicine. 100 (2024) - p. 104961 , 2024

Link: https://doi.org/10.1016/..

2

Fluorescence in situ hybridization reveals the evolutionary..:

Cui, Jian ; Liu, Yuntong ; Lv, Rui...
Leukemia. 38 (2024) 6 - p. 1299-1306 , 2024

Link: https://doi.org/10.1038/..

3

Subcutaneous daratumumab in Chinese patients with relapsed ..:

An, Gang ; Ge, Zheng ; Jing, Hongmei...
Blood Science. 6 (2024) 3 - p. e00193 , 2024

Link: https://doi.org/10.1097/..

4

Development and validation of an individualized and weighte..:

Mao, Xuehan ; Yan, Wenqiang ; Mery, David...
American Journal of Hematology. 99 (2024) 4 - p. 523-533 , 2024

Link: https://doi.org/10.1002/..

5

Dynamic monitoring of circulating tumor DNA reveals outcome..:

Zou, Hesong ; Liu, Wei ; Wang, Xiaojuan...
Journal for ImmunoTherapy of Cancer. 12 (2024) 3 - p. e008450 , 2024

Link: https://doi.org/10.1136/..

6

Plain language summary of zanubrutinib or ibrutinib in chro..:

Brown, Jennifer R ; Eichhorst, Barbara ; Hillmen, Peter...
Future Oncology. 20 (2024) 12 - p. 717-726 , 2024

Link: https://doi.org/10.2217/..

7

Venetoclax resistance leads to broad resistance to standard..:

Deng, Shuhui ; Derebail, Sanika ; Weiler, Vera Joy...
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

8

Sequential treatment escalation improves survival in patien..:

Yu, Ying ; Xiong, Wenjie ; Wang, Tingyu...
Blood Science. 6 (2024) 1 - p. e00179 , 2024

Link: https://doi.org/10.1097/..

9

Phase I study of the Syk inhibitor sovleplenib in relapsed ..:

Song, Yuqin ; Cao, Junning ; Zhang, Qingyuan...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

10

Novel Insights into the Initiation, Evolution, and Progress..:

Gong, Lixin ; Qiu, Lugui ; Hao, Mu
Cancers. 16 (2024) 3 - p. 498 , 2024

Link: https://doi.org/10.3390/..

11

Identification of therapy-induced clonal evolution and resi..:

Cui, Jian ; Li, Xiaoyun ; Deng, Shuhui...
Clinical Cancer Research. , 2024

Link: https://doi.org/10.1158/..

12

Monitoring Minimal Residual Disease in Patients with Multip..:

Fan, Huishou ; Wang, Bing ; Shi, Lihui...
Clinical Cancer Research. 30 (2024) 6 - p. 1131-1142 , 2024

Link: https://doi.org/10.1158/..

13

Study Design and Methodology of Antibiotic Duration in Hema..:

Feng, Xiaomeng ; Qian, Chenjing ; Fan, Yuping...
Clinical Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

14

LILRB4 represents a promising target for immunotherapy by d..:

Gong, Lixin ; Sun, Hao ; Liu, Lanting...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

15

Improved efficacy and safety of zanubrutinib versus ibrutin..:

Zhou, Keshu ; Wang, Tingyu ; Pan, Ling...
Annals of Hematology. , 2024

Link: https://doi.org/10.1007/..